T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.84B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.1B |
| 4 |
Bank of America
BAC
|
+$860M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$618M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.19B |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 3 |
JPMorgan Chase
JPM
|
+$1.29B |
| 4 |
Booking.com
BKNG
|
+$1.06B |
| 5 |
Merck
MRK
|
+$757M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Healthcare | 18.48% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 13.47% |
| 5 | Communication Services | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Kennametal
KMT
$2.43B
| $1.9M | ﹤0.01% |
51,730
+5,820
| +13% | +$213K |
|
|
BLD
1602
DELISTED
TopBuild
BLD
| $1.9M | ﹤0.01% |
29,274
+101
| +0.3% | +$5.68K |
|
1603
FirstCash
FCFS
$9.41B
| $1.9M | ﹤0.01% |
21,906
+113
| +0.5% | +$9.43K |
|
1604
RLJ Lodging Trust
RLJ
$1.69B
| $1.89M | ﹤0.01% |
107,302
+10,265
| +11% | +$187K |
|
|
USG
1605
DELISTED
Usg
USG
| $1.88M | ﹤0.01% |
43,494
+6,940
| +19% | +$299K |
|
1606
New York Times
NYT
$10.3B
| $1.87M | ﹤0.01% |
57,047
+362
| +0.6% | +$10.7K |
|
|
LTC
1607
LTC Properties
LTC
$2.32B
| $1.87M | ﹤0.01% |
40,762
+2,500
| +7% | +$112K |
|
1608
Hallador Energy
HNRG
$678M
| $1.86M | ﹤0.01% |
353,217
+131,941
| +60% | +$714K |
|
1609
Brinker International
EAT
$8.46B
| $1.85M | ﹤0.01% |
41,760
+2,893
| +7% | +$130K |
|
1610
Enpro
NPO
$6.51B
| $1.85M | ﹤0.01% |
28,748
-13,650
| -32% | -$900K |
|
1611
Brown-Forman Class A
BF.A
$12.2B
| $1.84M | ﹤0.01% |
36,000
| – | – |
|
1612
Regal Rexnord
RRX
$10.4B
| $1.83M | ﹤0.01% |
22,310
+120
| +0.5% | +$9.47K |
|
|
MPT
1613
Medical Properties Trust
MPT
$2.09B
| $1.82M | ﹤0.01% |
98,552
+1,104
| +1% | +$19.7K |
|
|
BCPC
1614
Balchem Corp
BCPC
$5.38B
| $1.82M | ﹤0.01% |
19,654
+791
| +4% | +$68.2K |
|
1615
Viavi Solutions
VIAV
$10.1B
| $1.82M | ﹤0.01% |
147,185
-673,146
| -82% | -$7.89M |
|
1616
Medifast
MED
$131M
| $1.81M | ﹤0.01% |
14,206
+8,068
| +131% | +$1.02M |
|
|
WBT
1617
DELISTED
Welbilt, Inc.
WBT
| $1.81M | ﹤0.01% |
110,284
-72,309
| -40% | -$1.06M |
|
|
UN
1618
DELISTED
Unilever NV New York Registry Shares
UN
| $1.79M | ﹤0.01% |
30,682
+650
| +2% | +$35.7K |
|
|
CPE
1619
DELISTED
Callon Petroleum Company
CPE
| $1.77M | ﹤0.01% |
23,473
+3,771
| +19% | +$292K |
|
|
CORE
1620
DELISTED
Core Mark Holding Co., Inc.
CORE
| $1.77M | ﹤0.01% |
47,727
+8,120
| +21% | +$255K |
|
1621
Dick's Sporting Goods
DKS
$13.2B
| $1.76M | ﹤0.01% |
47,917
+281
| +0.6% | +$10K |
|
|
CLDT
1622
Chatham Lodging
CLDT
$621M
| $1.76M | ﹤0.01% |
91,412
+100
| +0.1% | +$1.97K |
|
|
MDR
1623
DELISTED
McDermott International
MDR
| $1.75M | ﹤0.01% |
235,776
+12,936
| +6% | +$107K |
|
1624
Merit Medical Systems
MMSI
$5.19B
| $1.75M | ﹤0.01% |
28,350
+4,440
| +19% | +$252K |
|
1625
LiveRamp
RAMP
$2.29B
| $1.75M | ﹤0.01% |
32,105
+538
| +2% | +$26.7K |
|
Similar funds
T. Rowe Price Associates's Q1 2019 Portfolio in Review
As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q1 2019 filing shows 56 new, 1,633 increased, 713 reduced and 86 closed positions. Its largest new stake was Fox Class B: 11,707,204 shares worth $420M. The largest sale was Tesla, an estimated $2.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
- T. Rowe Price Associates's biggest Q1 2019 reduction was Tesla, cutting an estimated $2.19B.
- T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
- T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
- T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.